Molecular Pathology (MoPath): Reimbursement for Dates of Service 01/01/13 -09/30/13 (revised 09/17/2013)
As instructed by CMS, CGS Administrators has determined a gap fill allowance for the 2013 MoPath CPT codes. The fees were based on the gap-filled process instructions found in CFR §414.508.
Claims Submission
All services to produce the assay result were evaluated and included in the listed fee. CGS has also included the coverage determination established during the review of available literature. We will continue to update this fee schedule as the remaining MoPath services are evaluated. The reimbursement amounts listed below are for dates of service January 1, 2013 thru September 30, 2013.
Important: Before you submit claims for molecular pathology tests, reference the "Required Text" (column 3, in the following table). Column 3 "Required Text" lists key components needed to adjudicate the claim. The first capitalized text in this column represents the acronym for the gene. The acronym is separated by a comma and the following text identifies the components evaluated on the gene including but not limited to the following items: a specific variant, known familial variant, duplication/deletions, exons, and full gene sequence. The table following the MoPath Fee Schedule provides a comprehensive abbreviation key for the test components.
- Additional services should not be submitted in addition to the appropriate CPT code for your assay.
- To submit claims for MoPath services, enter the appropriate acronym and the information following the comma in Loop 2400, NTE02, or SV101-7 field for electronic claims for each CPT code used to report the test. For paper claims, submit this information in Item 19.
Claims submitted without the required descriptor information will be rejected as invalid claims (remark code MA130).
Special Alert — For services that were submitted prior to April 14, 2013 for level 1 MoPath services (CPT codes 81200-81383), CGS will perform a mass adjustment on codes that were listed in the April 8, 2013 revision of this reimbursement schedule with a price increase. For any level 2 MoPath services (CPT codes 81400-81408) that are listed with a price increase, CGS is requesting lab providers to submit a reopening request to have claims adjusted with the corrected price.
Column 5 "Covered" key Indicator | Description |
---|---|
Y | Payable Medicare service |
SE | Not covered - statutorily excluded from Medicare benefit |
N | Not covered –failed reasonable/necessary Medicare criteria |
L | Limited coverage per published LCD |
CPT Code | Descriptor | Required Text | CGS | Covered | Comment |
---|---|---|---|---|---|
81161 | DMD Dup/Delet AnalysisDMD (dystrophin) (eg, Duchene/Becker muscular dystrophy) deletion analysis, and duplication analysis, if performed | DMD, dup_del | No Data | SE | |
81200 | Aspa gene | ASPA, cv | $93.90 | SE | |
81201 | APC (adaenomatous polyposis coli full gene sequence) | APC, fgs | $749.92 | SE | |
81202 | known familial variants | APC, kfv | $93.94 | SE | |
81203 | duplication/deletion | APC, dup_del | $570.05 | SE | |
81205 | Bckdhb gene | BCKDHB, cv | $123.36 | SE | |
81206 | Bcr/abl 1 gene major bp | BCR_ABL1, majbp qual quant | $108.37 | Y | |
81207 | Bcr/abl 1 gene minor bp | BCR_ABL1, minbp qual quant | $90.31 | Y | |
81208 | Bcr/abl 1 gene other bp | BCR_ABL1, other bp qual quant | $150.17 | Y | |
81209 | Blm gene | BLM, 2281 del6ins7 | $93.90 | SE | |
81210 | Braf gene | BRAF, V600E | $97.45 | Y | |
81211 | BRCA 1 & 2 seq and com dup/del | BRCA1, BRCA2, fgs cdup_del | $2795.09 | Y | |
81212 | BRCA 1 & 2 185, 58385, &617 var | BRCA, BRCA2, 185delAG, 5385insC,6174delT | $178.04 | Y | |
81213 | BRCA 1 & 2 uncom dup/del | BRCA1, BRCA2, uncom dup del | $587.12 | Y | |
81214 | BRCA 1 full seq & com dup/del | BRCA1, fgscdup_del | $1449.01 | Y | |
81215 | Brca 1 full gene known fam variant | BRCA1, fgs, kfv | $93.94 | Y | |
81216 | BRCA 2 gene full sequence | BRCA2, fgs | $1,747.04 | SE | |
81217 | Brca 2 gene known fam variant | BRCA2, kfv | $93.94 | Y | |
81220 | CFTR gene com variants | CFTR, cv | $800.46 | SE | |
81221 | Cftr gene known fam variants | CFTR, kfv | $93.94 | SE | |
81222 | CFTR gene dup/del variants | CFTR, dup_del | $129.55 | SE | |
81223 | Cftr gene full sequence | CFTR, fgs | $1,554.46 | SE | |
81224 | Cftr gene intron poly t | CFTR, intron 8 poy-T | $82.58 | SE | |
81225 | Cyp2c19 gene com variants | CYP2C19, cv | $319.12 | Y | |
81226 | Cyp2d6 gene com variants | CYP2D6, cv | $426.43 | Y | Coverage Change |
81227 | Cyp2c9 gene com variants | CYP2C9, cv | $169.50 | N | Coverage Change |
81228 | Cytogen micrarray copy nmbr | Cytogen microarray copy nmbr | $646.14 | SE | |
81229 | Cytogen m array copy no&snp | Cytogen microarray copy nmbr and SNP | $675.56 | SE | |
81235 | EGFR (epidermal growth receptor)(non-small cell lung) gene analysis, common variants (eg exon 19 LREA deletion, L858R, T790M, G719A, G719S, L861Q) | EGFR, cv | $225.00 | Y | |
81240 | F2 gene | F2, 20210G>A | $41.41 | Y | |
81241 | F5 gene | F5, Leiden | $78.39 | Y | |
81242 | Fancc gene | FANCC, cv | $93.90 | SE | |
81243 | Fmr1 gene detection | FMR1 | $60.51 | SE | |
81244 | Fmr1 gene characterization | FMR1, ma | $100.09 | SE | |
81245 | Flt3 gene | FLT3, dup | $112.00 | Y | |
81250 | G6pc gene | G6PC, cv | $93.90 | SE | |
81251 | Gba gene | GBA, cv | $93.90 | SE | |
81252 | GJB2(gap junction protein, common variants | GJB2, fgs | $156.64 | SE | |
81253 | known familial variants | GJB2, kfv | $81.56 | SE | |
81254 | GJB6 gap junction protein gene analysis, common variants | GJB6, cv | $74.97 | SE | |
81255 | Hexa gene (Tay Sachs) | HEXA, cv | $93.90 | SE | |
81256 | Hfe gene | HFE, cv | $70.20 | Y | |
81257 | Hba1/hba2 gene | HBA1_HBA2, cdel or v | $183.22 | SE | |
81260 | Ikbkap gene | IKBKAP, cv | $93.90 | SE | |
81261 | lgh gene rearrange amp meth | IGH, amp | $148.12 | Y | |
81262 | lgh gene rearrange dir probe | IGH, dp | $51.12 | Y | |
81263 | lgh vari regional mutation | IGH, variable region | $259.93 | Y | |
81264 | lgk rearrange bn clonal pop | IGK. Gr | $111.98 | Y | |
81265 | Str markers specimen anal | STR | $414.94 | Y | Coverage Change |
81266 | STR markers and addl | STR add | No Data | SE | Coverage Change |
81267 | Chimerism anal no cell selec | Chimerism | $149.72 | Y | |
81268 | Chimerism anal w/cell selec | Chimerism, add cell | $149.72 | Y | |
81270 | Jak2 gene | JAK2, V617F | $82.88 | Y | |
81275 | Kras gene | KRAS, codons 12 and 13 | $246.40 | Y | |
81280 | Long qt synd gene full sequence (12 genes) | LQT, fgs 12 genes | No Data | SE | |
81281 | Long qt synd known fam var | LQT, kfv | No Data | SE | |
81282 | Long qt syn gene dup/dlt var (12 genes) | LQT, dup_del 12 genes | No Data | SE | |
81290 | Mcoln1 gene | MCOLN1, cv | $93.90 | SE | |
81291 | Mthfr gene | MTHFR, cv | $92.92 | Y | |
81292 | Mlh 1 gene full seq | MLH1, fgs | $803.28 | Y | |
81293 | Mlh 1 gene known variants | MLH1, kfv | $93.94 | Y | |
81294 | Mlh 1 gene dup/delete variant | MLH1, dup_del | $491.96 | Y | |
81295 | Msh2 gene full seq | MSH2, fgs | $787.22 | Y | |
81296 | Msh2 gene known variants | MSH2, kfv | $93.94 | Y | |
81297 | Msh2 gene dup/delete variants | MSH2, dup_del | $542.77 | Y | |
81298 | Msh6 gene full seq | MSH6, fgs | $617.61 | Y | |
81299 | Msh6 gene known variants | MSH6, kfv | $93.94 | Y | |
81300 | Msh6 gene dup/delete variants | MSH6, dup_del | $505.15 | Y | |
81301 | Microsatellite instability | MSI | $320.84 | Y | |
81302 | Mecp2 gene full seq(Rhetts) | MECP2, fgs | $312.94 | SE | |
81303 | Mecp2 gene known variant(Rhetts) | MECP2, kfv | $117.68 | SE | |
81304 | Mecp2 gene dup/delete variants (Rhetts) | MECP2, dup_del | $85.42 | SE | |
81310 | Npm1 gene | NPM1, exon 12 | $58.84 | Y | |
81315 | Pml/raralpha com breakpoints | PML_RAR, sbp quant qual | $117.54 | Y | |
81316 | PML/RARalpha com 1 breakpoint | PML_RAR, sbp quant qual | No Data | Y | Coverage Change |
81317 | Prms2 gene full seq analysis | PMS2, fgs | $642.58 | Y | |
81318 | Prms2 known familial variants | PMS2, dup_del | $93.94 | Y | |
81319 | Prms2 gene dup/delete variants | PMS2, dup_del | $462.42 | Y | |
81321 | PTEN gene analysis, full sequence | PTEN, fgs | $605.24 | Y | |
81322 | known familial variants | PTEN, kfv | $58.84 | Y | |
81323 | duplication/deletion | PTEN, dup_del | $88.26 | Y | |
81324 | PMP22 gene analysis, duplication/deletion | PMP22, dup_del | $486.16 | SE | |
81325 | full sequence analysis | PMP22, fgs | $297.24 | SE | |
81326 | known familial variants | PMP22, kfv | $93.94 | SE | |
81330 | Smpd1 gene common variants | SMPD1, cv | $93.90 | SE | |
81331 | snrpn/ube3a gene | SNRPN_UBE3A, ma | $73.22 | SE | |
81332 | Serpina1 gene | SERPINA, cv | $70.20 | Y | |
81340 | Trb@gene rearrange amplify | TRB, beta amp | $148.12 | Y | |
81341 | Trb@gene rearrange dirporbe | TRB, dp | $45.44 | Y | |
81342 | Trg gene rearrangement anal | TRG, gamma | $148.12 | Y | |
81350 | Ugl1 a1 gene | UGT1A1, cv | $67.25 | SE | |
81355 | Vkorc1 gene | VKORC1, cv | $83.19 | N | Coverage Change per NCD |
81370 | HLA I & II typng lr | HLA I-II, lr | $552.75 | Y | |
81371 | HLA I & II type verify lr | HLA I-II, lr A, B, DRB | $330.84 | Y | |
81372 | HLA I typing complete lr | HLA I, lr complete | $303.64 | Y | |
81373 | HLA I typing 1 locus lr | HLA I lr locus ea | $153.08 | Y | |
81374 | HLA I typing 1 antigen lr | HLA I, lr antigen ea | $100.00 | Y | |
81375 | HLA II typing ag equiv lr | HLA II, lr DRB1, DQB1 | $303.43 | Y | |
81376 | HLA II typing 1 locus lr | HLA II, lr locus ea | $168.00 | Y | |
81377 | HLA II type 1 ag equiv lr | HLA II, lr antigen ea | $126.20 | Y | |
81378 | HLA I & II typing hr | HLA I-II, hr | $475.00 | Y | |
81379 | HLA I typing complete hr | HLA I, hr complete | $461.00 | Y | |
.81380 | HLA I typing 1 locus hr | HLA I, hr locus ea | $243.64 | Y | |
81381 | HLA I typing 1 allele hr | HLA I, hr allele ea | $130.00 | Y | |
81382 | HLA II typing 1 loc hr | HLA II, hr locus ea | $170.00 | Y | |
81383 | HLA II typing 1 allele hr | HLA II, hr allele ea | $150.00 | Y | |
81400 | Tier 2 | MoPath Procedure Level 1 | |||
81400 | ABCC8 | ABCC8, F1388del | No Data | SE | |
81400 | ACADM | ACADM, K304E | $99.62 | SE | |
81400 | ACE | ACE, idv | $82.58 | Y | |
81400 | AGTR1 | AGTR1, 1166A>C | $75.88 | SE | |
81400 | CCR5 | CCR5, del | $75.88 | SE | |
81400 | CLRN1 | CLRN1, N48K | $93.94 | SE | |
81400 | DPYD | DPYD, IVS14+1G>A | $81.70 | SE | |
81400 | DYT1 (TOR1A) | DYT1(TOR1A), IVS14+1G>A | $106.32 | SE | |
81400 | F13B | F13B, V34L | $70.20 | Y | |
81400 | F2 (for 20210G>A) | F2, 20210G>A | $41.41 | Y | |
81400 | F2( for 1199G>A) | F2, 1199G>A | $70.20 | Y | |
81400 | F5 | F5, HR2 | $64.52 | Y | |
81400 | F7 | F7R353Q | $64.52 | Y | |
81400 | FGB | FGB, -455G>A | $70.20 | Y | |
81400 | FGFR3 | FGFR3, P250R | $52.14 | SE | |
81400 | Human Platelet Antigen ANTIGEN 1(HPA-1) | HPA, antigen ea | $46.46 | Y | |
81400 | Human Platelet Antigen ANTIGEN 15 (HPA-15) | HPA, antigen ea | $46.46 | Y | |
81400 | Human Platelet Antigen ANTIGEN 2(HPA-2) | HPA, antigen, ea | $46.46 | Y | |
81400 | Human Platelet Antigen ANTIGEN 3(HPA-3) | HPA, antigen ea | $46.46 | Y | |
81400 | Human Platelet Antigen ANTIGEN 4(HPA-4) | HPA, antigen ea | $46.46 | Y | |
81400 | Human Platelet Antigen ANTIGEN 5(HPA-5) | HPA, antigen ea | $46.46 | Y | |
81400 | Human Platelet Antigen ANTIGEN 6(HPA-6w) | HPA, antigen ea | $46.46 | Y | |
81400 | Human platelet antigen Antigen 9 (HPA-9), | HPA, antigen ea | $46.46 | Y | |
81400 | IVD | IVD, A282V | $46.46 | SE | |
81400 | SERPINE1 | SERPINE1, 4G | $58.84 | Y | |
81400 | SHOC2-Noonan-Like Syndrome | SHOC2, S2G | No Data | SE | |
81400 | SMN1 | SMN1, exon 7 del | $70.20 | SE | |
81400 | SRY | SRY | No Data | SE | |
81401 | Tier 2 | Mopath procedure level 2 | |||
81401 | ABL1 (c-abl oncogene 1) | ABL1, T315I | $153.01 | Y | |
81401 | ACADM (acy-CoA dehydrogenase) | ACADM, cv | No Data | SE | |
81401 | ADRB2 | ADRB2, cv | $55.49 | SE | |
81401 | APOB | APOB, cv | No Data | SE | |
81401 | APOE | APOE, cv | $46.46 | SE | |
81401 | AR (androgen receptor) | AR, alleles | No Data | SE | |
81401 | ATN1 | ATN1 | $58.84 | SE | |
81401 | CBFB/MYH11 | CBFB_MYH11, quan qual | No Data | SE | |
81401 | CBS | CBS, cv | No Data | SE | |
81401 | CCND1/IGH | CCND1_IGH, ta majbp qual qual | $93.94 | Y | |
81401 | CFH/ARMS2 | CFH_ARMS2, cv | $90.59 | SE | |
81401 | CYP3A4 | CYP3A4, cv | $46.46 | SE | |
81401 | CYP3A5 | CYP3A5, cv | $46.46 | SE | |
81401 | CYFB-MYH11 | CYFB_MYH11, cv | $138.82 | Y | |
81401 | DMPK (dystrophia myotonica-protein kinase) | DMPK | $66.41 | SE | |
81401 | E2A/PBX1 | E2A_PBX1, ta qual quan | $105.30 | Y | |
81401 | EML4-ALK | EML4_ALK, ta or ia | $128.48 | Y | |
81401 | ETV6-RUNX1 | ETV6_RUNX1, ta qual quan | $90.31 | Y | |
81401 | EWSR1/ERG | EWSR1_ERG, ta qual quan | $151.42 | Y | |
81401 | EWSR1/FLI1 | EWSR1_FLI1, ta qual quan | $162.85 | Y | |
81401 | EWSR1/WT1 | EWSR1_WT1, ta qual quan | $203.84 | Y | |
81401 | F11 coagulation factor XI | F11, cv | $75.88 | Y | |
81401 | FGFR3 | FGFR3, cv | $84.91 | SE | |
81401 | FIP1L1-PDGFR | FIP1L1_PDGFR, qual quan | $90.82 | Y | |
81401 | FOXO1/PAX3 | FOXO1_PAX3, ta, qual quan | $120.75 | Y | |
81401 | FOXO1/PAX7 | FOXO1_PAX7, ta, qual quan | $120.75 | Y | |
81401 | FXN (frataxin) | FXN, alleles | No Data | SE | |
81401 | GALT (galactose-1-phosphate uridylyltransferase) | GALT, cv | $299.08 | SE | |
81401 | H19 | H19, ma | $112.00 | SE | |
81401 | HBB (hemoglobin, beta) | HBB, cv | $147.81 | SE | |
81401 | HTT (huntingtin) | HTT, alleles | $82.58 | SE | |
81401 | KCNQ10T1 (KCNQ1 overlapping transcript 1) | KCNQ10T1, ma | No Data | SE | |
81401 | MEG3/DLK1 | MEG3_DLK1, ma | No Data | SE | |
81401 | MLL/AFF | MLL_AFF1, ta qual quan | $101.67 | SE | |
81401 | MLL/MLLT3 | MLL_MLLT3, ta, qual quan | No Data | SE | |
81401 | MT-ATP6 | MT-ATP6, cv | No Data | SE | |
81401 | MT-ND4, MT-ND6 | MT-ND4, MT-ND6, cv | $131.08 | SE | |
81401 | MT-ND5 mitochondrially encoded tRNA leucine 1 (UUA/G) mitochondrially encoded NADH dehydrogenase 5) | MT-ND5, cv | $183.22 | SE | |
81401 | MT-RNR1 (mitochondrially encoded 12S RNA) | MT-RNR1, cv | $85.93 | SE | |
81401 | MT-TK (mitochondrially encoded tRNA lysine) | MT-TK, cv | No Data | SE | |
81401 | MT-TL1 | MT-TL1, cv | No Data | SE | |
81401 | MT-TS1 | MT-TS1, cv | $130.38 | SE | |
81401 | MUTYH (mutY homolog (E.coli)) | MUTYH, cv | $82.07 | Y | |
81401 | NPM/ALK | NPM_ALK, ta | No Data | Y | |
81401 | PAX8/PPARG | PAX8_PPARG, ta | $54.19 | Y | |
81401 | PRSS1 (protease, serine, 1 (trypsin 1)) | PRSS1, cv | $105.30 | SE | |
81401 | PYGM | PYGM, cv | No Data | SE | |
81401 | RUNX1/RUNX1T1 | RUNX1_RUNX1T1, ta qual quan | $106.05 | Y | |
81401 | SEPT9 (Septin 9) | SEPT9, ma | $90.59 | SE | |
81401 | SMN1/SMN2 (survival of motor neuron 1, telomeric/survival of motor neuron 2, centromeric) | SMN1_SMN2, dosage | $74.75 | SE | |
81401 | TPMT (thiopurine S-methyltransferase) | TPMT, cv | $111.61 | Y | |
81401 | TYMS (thymidylate synthetase) | TYMS, trv | $169.10 | Y | |
81401 | VWF (von Willebrand factor) | VWF, cv | $278.18 | Y | |
81402 | Mopath procedure level 3 | ||||
81402 | CYP21A2 | CYP21A2, cv | $390.18 | SE | |
81402 | Chromosome 18q | C18q | No Data | SE | |
81402 | ESR1/PGR | ESR1_PGR, ratio | No Data | SE | |
81402 | IGH/BCL2 | IGH_BCL2, majbpr and mcr bp qual quan | No Data | Y | |
81402 | KIT | KIT, cv | $98.13 | Y | |
81402 | MEFV (Mediterranean fever) (e.g., familial Mediterranean fever) | MEFV, cv | $138.58 | SE | |
81402 | MPL | MPL, cv | $101.45 | SE | |
81402 | TRD | TRD, gr | No Data | N | |
81402 | Uniparental disomy (UPD) | UPD, str | $130.05 | N | |
81403 | Mopath procedure level 4 | ||||
81403 | ABL1 (c-abl oncogene 1) | ABL1 | $156.89 | Y | |
81403 | ANG (angiogenin, ribonuclease, RNase A family, 5) | ANG, fgs | No Data | SE | |
81403 | CEBPA | CEBPA, fgs | $235.54 | Y | |
81403 | CEL (carboxyl ester lipase[bile salt-stimulated lipase]) | CEL, exon 11 | No Data | SE | |
81403 | DAZ/SRY | DAZ_SRY, cdel | No Data | SE | |
81403 | F8 (coagulation factor VIII) | F8, intron 1 and 22a | $81.05 | Y | |
81403 | FGFR3 (fibroblast growth factor receptor 3) one exon | FGFR, exon 7 | $88.26 | SE | |
81403 | GJB1 (gap junction protein, beta 1) (e.g., Charcot-Marie-Tooth X linked), full gene sequence | GJB1, fgs | No Data | SE | |
81403 | HBB (hemoglobin, beta, beta-globin, beta thalassemia) | HBB, dup_del | No Data | SE | |
81403 | HRAS (v-Ha-ras Harvey rat sarcoma viral oncogene homolog Costello syndrome) | HRAS, exon 2 | $88.33 | SE | |
81403 | IDH1 | IDH1, exon 4 | $67.70 | Y | |
81403 | IDH2 (isocitrate dehydrogenase 2) | IDH2, exon 4 | $67.70 | Y | |
81403 | JAK2 (Janus kinase 2) | JAK2, exon 12 and 13 | $109.14 | Y | |
81403 | KRAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene) | KRAS, exon 3 | No Data | SE | |
81403 | MPL (myeloproliferative leukemia virus oncogene, thrombopoietin receptor, TPOR) | MPL, exon 10 | $106.32 | SE | |
81403 | MT-RNR1 (mitochondrially encoded 12S RNA) | MT-RNR1, fgs | $114.72 | SE | |
81403 | MT-TS1 (mitochondrially encoded tRNA serine 1) | MT-TS1, fgs | $114.72 | SE | |
81403 | SMN1 (survival of motor neuron 1, telomeric) | SMN1, kfv | No Data | SE | |
81403 | VHL (von Hippel-Lindau tumor suppressor) | VHL, dup_del | $83.60 | Y | |
81403 | VWF (von Willebrand factor) | VWF, tsa | $284.20 | Y | |
81404 | Mopath procedure level 5 | ||||
81404 | ACADS (acyl-CoA dehydrogenase) | ACADS, tsa | $247.74 | SE | |
81404 | AQP2 (aquaporin 2 [collecting duct]) | AQp2, fgs | No Data | SE | |
81404 | ARX ( aristaless related homebox) | ARX, fgd | No Data | SE | |
81404 | BTD (biotinidase) | BTD, fgs | $328.05 | SE | |
81404 | CAV3 (caveolin 3) (e.g., CAV3- related distal myopathy, limb-girdle muscular dystrophy type 1C), full gene sequence | CAV3, fgs | No Data | SE | |
81404 | CDKN2A (cyclin-dependent kinase inhibitor 2A) | CDKN2A, fgs | $373.14 | Y | |
81404 | CLRN1 (clarin 1) | CLRN1, fgs | No Data | SE | |
81404 | CPT2 (caritine palmitoyltransferase) | CPT2, fgs | No Data | SE | |
81404 | CYP1B1 (cytochrome P450, family 1, subfamily B, polypeptide 1) | CYP1B1, fgs | $278.18 | SE | |
81404 | DMPK (dystrophia myotonica-protein kinase) | DMPK | $66.41 | SE | |
81404 | EGR2 (early growth response 2) (e.g., Charcot-Marie-Tooth) | EGR2, fgs | $296.24 | SE | |
81404 | FGFR2 (fibroblast growth factor receptor 2) (2 EXONS) | FGFR2, exons 8, 10 | $368.90 | SE | |
81404 | FGFR3 (fibroblast growth factor receptor 3) (4 EXONS) | FGFR3, exons 8, 11, 12, 13 | $280.51 | SE | |
81404 | FKRP (Fukutin related protein) | FKRP, fgs | No Data | SE | |
81404 | FOXG1 (forkhead box G1) | FOXG1, fgs | $325.66 | SE | |
81404 | FSHD1A (facioscapulohumeral muscular dystrophy 1A) | FSHMD1A | No Data | SE | |
81404 | FXN (frataxin) | FXN, fgs | No Data | SE | |
81404 | HBA1/HBA2 (alpha globin 1 and alpha globin 2) | HBA1_HBA2, dup_del | No Data | SE | |
81404 | HBB (hemoglobin, beta, beta-globin) | HBB, fgs | $206.96 | SE | |
81404 | HNF1B (HNF1 homeobox B) (eg maturity-onset diabetes of the young type 5) | HNF1B, dup_del | No Data | SE | |
81404 | HRAS (v-Ha-ras Harvey rat sarcoma viral oncogene homolog) | HRAS, fgs | No Data | SE | |
81404 | KCNJ10 (potassium inwardly-rectifying channel, subfamily J, member 10) | KCNJ10, fgs | No Data | SE | |
81404 | KIT (C-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma) | KIT, tga | $213.47 | Y | |
81404 | LITAF (lipopolysaccharide-induced TNF factor) | LITAF, fgs | No Data | SE | |
81404 | MEFV (Mediterranean fever) | MEFV, fgs | $329.41 | SE | |
81404 | MEN1 (multiple endocrine neoplasia type 1) | MEN1, dup_del | No Data | SE | |
81404 | NRAS (neuroblastoma RAS viral oncogene homolog) | NRAS, exon 1, 2 | $148.04 | Y | |
81404 | PDGFRA (platelet-derived growth factor receptor alpha polypeptide) | PDGFRA,tsa | $111.44 | Y | Text change |
81404 | PDX1 (pancreatic and duodenal homeobox) | PDX1, fgs | No Data | SE | |
81404 | PRNP (prion protein) | PRNP, fgs | No Data | SE | |
81404 | PRSS1 (protease, serine, 1 [trypsin 1]) | PRSS1, fgs | $248.76 | Y | |
81404 | RAF1 (v-raf-murine leukemia viral oncogene homolog 1) | RAF1, exons7, 12, 14, 17 | No Data | SE | |
81404 | RET (RET proto-oncogene) | RET, cv | No Data | SE | |
81404 | SDHD (succinate dehydrogenase complex, subunit D, integral membrane protein) | SDHD, fgs | No Data | SE | |
81404 | SLC25A4 (solute carrier family 25 [mitochondrial carrier; adenine nucleotide translocation] | SLC25A4, fgs | No Data | SE | |
81404 | TP53 (tumor protein 53) | TP53, 2-5 exons | No Data | SE | |
81404 | TRR (Transthyretin) | TTR, fgs | No Data | SE | |
81404 | TYR (tyrosinase [oculocutaneous albinism IA]) | TYR, fgs | No Data | SE | |
81404 | USH1G (Usher syndrome 1G[autosomal recessive]) | USH1G, fgs | No Data | SE | |
81404 | VHL (von Hippel-Lindau tumor suppressor) | VHL, fgs | $639.96 | Y | |
81404 | VWF (Von Willebrand factor) | VWF, tsa | No Data | SE | |
81405 | Mopath procedure level 6 | ||||
81405 | ABCD1 (ATP-binding cassette, sub-family D [ALD] | ABCD1, fgs | No Data | SE | |
81405 | ACADS (acyl-CoA dehydrogenase, C-2 to C-3 short chain) (e.g., short chain acyl-CoA) | ACADS, fgs | No Data | SE | |
81405 | ACTC1 (actin, alpha, cardiac muscle 1) | ACTC1, fgs | No Data | SE | |
81405 | APTX (aprataxin) | APTX, fgs | No Data | SE | |
81405 | AR (androgen receptor) | AR, fgs | No Data | SE | |
81405 | CHRNA4 (cholinergic receptor, nicotine, alpha 4) | CHRNA4, fgs | No Data | SE | |
81405 | CHRNB2 (cholinergic receptor, nicotinic, beta 2 neuronal) | CHRNB2, fgs | No Data | SE | |
81405 | CYP21A2 (cytochrome P450, family 21, subfamily A, polypeptide2) | CYP21A2, fgs | $147.10 | SE | |
81405 | DFNB59 (deafness, autosomal recessive 59) | DFNB59, fgs | No Data | SE | |
81405 | DHCR7 (7-dehydrocholesterol reductase) | DHCR7, fgs | No Data | SE | |
81405 | EYA1 (eyes absent homolog 1 [Drosophila]) | EYA1, dup_del | No Data | SE | |
81405 | F9 (coagulation factor IX) | F9, fgs | No Data | SE | |
81405 | FH (fumarate hydratase) | FH, fgs | No Data | SE | |
81405 | FKTN (fukutin) (e.g., limb-girdle muscular dystrophy) | FKTN, fgs | No Data | SE | |
81405 | GFAP (glial fibrillary acidic protein) | GFAP, fgs | No Data | SE | |
81405 | GLA (galactosidase, alph) | GLA, fgs | No Data | SE | |
81405 | HBA1/HBA2 (alpha globin 1 and alpha globin 2) | HBA1_HBA2, fgs | No Data | SE | |
81405 | HNF1A (HNF1 homeobox A) | HNF1A, fgs | No Data | SE | |
81405 | HNF1B (HNF1 homeobox B) | HNF1B, fgs | No Data | SE | |
81405 | KRAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) | KRAS, fgs | No Data | SE | |
81405 | LAMP2 (lysosomal-associated membrane protein 2) | LAMP2, fgs | No Data | SE | |
81405 | MEN1 (multiple endocrine neoplasia) | MEN1, fgs | $426.32 | Y | |
81405 | MPZ (myelin protein zero) | MPZ, fgs | $296.24 | SE | |
81405 | MYL2 (myosin, light chain 2, regulatory, cardiac, slow) | MYL2, fgs | No Data | SE | |
81405 | MYL3 (myosin, light chain 3, alkali, ventricular, skeletal, slow) | MYL3, fgs | No Data | SE | |
81405 | MYOT (myotilin) | MYOT, fgs | No Data | SE | |
81405 | NEFL (neurofilament, light polypeptide) | NEFL, fgs | No Data | SE | |
81405 | NF2 (neirofibromin 2 [Merlin]) | NF2, dup_del | No Data | SE | |
81405 | NSD1 (nuclear receptor binding SET domain protein 1) | NSD1, dup_del | No Data | SE | |
81405 | OTC (ornithine carbamoyltransferase) | OTC, fgs | No Data | SE | |
81405 | PDHB (pyruvate dehydrogenase [lipoamide] beta) | PDHB, fgs | no Data | SE | |
81405 | PSEN1 (presenilin 1) | PSEN1, fgs | No Data | SE | |
81405 | RET (RET proto-oncogene) (e.g., multiple endocrine neoplasia, type 2A and familial medullary thyroid carcinoma) | RET, tsa | No Data | SE | |
81405 | SDHB (succinate dehydrogenase complex, subunit B, iron sulfur) (e.g.hereditary paraganglioma-pheochromocytoma type 4) | SDHB, fgs | No Data | SE | |
81405 | SDHC (succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa) | SDHC, fgs | No Data | SE | |
81405 | SGCA (sarcoglycan, alpha [50kDa dystrophin-associated glycoprotein]) | SGCA, fgs | No Data | SE | |
81405 | SGCB (sarcoglycan, beta [43kDa dystrophin-associated glycoprotein]) | SGCB, fgs | No Data | SE | |
81405 | SGCD (sarcoglycan, delta [35kDa dystrophin-associated glycoprotein]) | SGCD, fgs | No Data | SE | |
81405 | SGCG (sarcoglycan, gamma [35kDa dystrophin-associated glycoprotein]) | SGCG, fgs | No Data | SE | |
81405 | SHOC2 (soc-2 suppressor of clear homolog) | SHOC2, fgs | No Data | SE | |
81405 | SMN1 (survival of motor neuron 1, telomeric) | SMN1, fgs | No Data | SE | |
81405 | SPRED1 (sprouty-related, EVH1 domain containing 1) | SPRED1, fgs | No Data | SE | |
81405 | TGFBR1 (transforming growth factor, beta receptor 1) | TGFBR1, fgs | No Data | SE | |
81405 | TGFBR2 (transforming growth factor, beta receptor 2) | TGFBR2, fgs | No Data | SE | |
81405 | THRB (thyroid hormone receptor, beta) | THRB, fgs>5 exons | No Data | SE | |
81405 | TNNI3 (troponin 1, type 3 [cardiac]) | TNNI3, fgs | No Data | SE | |
81405 | TP53 (tumor protein 53) (e.g., Li-Fraumeni syndrome, tumor) | TP53, fgs or tsa>5 | No Data | SE | |
81405 | TPM1 (tropomyosin 1 [alpha]) | TPM1, fgs | No Data | SE | |
81405 | TSC1 (tuberous sclerosis 1) | TSC1, dup_del | No Data | SE | |
81405 | VWF (von Willebrand factor) | VWF, tsa | $292.63 | Y | |
81406 | Mopath procedure level 7 | ||||
81406 | ACADVL (acyl-CoA dehydrogenase, very long chain) | ACADVL, fgs | No Data | SE | |
81406 | ACTN4 (actinin, alpha 4) | ACTN4, fgs | No Data | SE | |
81406 | ANO5 (anoctamin 5) | ANO5 | $331.85 | SE | |
81406 | APP (amyloid beta [A4] precursor protein) | APP, fgs | No Data | SE | |
81406 | ATP7B (ATPase, Cu++ transporting, beta polypeptide) | ATP7B, fgs | No Data | SE | |
81406 | BRAF (v-raf murine sarcoma viral oncogene homolog B1) | BRAF, fgs | No Data | SE | |
81406 | CAPN3 (Calpain 3) | CAPN3, fgs | $538.98 | Y | |
81406 | CBS (cystathionine-beta-synthase) | CBS, fgs | No Data | SE | |
81406 | CDH1 (cystathionine-beta-synthase) | CDH1, fgs | No Data | SE | |
81406 | CDKL5 (cyclin-dependent kinase-like 5) | CDKL5, fgs | $120.88 | SE | |
81406 | DLAT (dihydrolipoamide S-acetyltransferase) | DLAT, fgs | No Data | SE | |
81406 | DLD (dihydrolipoamide dehydrogenase) | DLD, fgs | $561.68 | SE | |
81406 | EYA1 (eyes absent homolog 1 [Drosophila]) | EYA1, fgs | $402.56 | SE | |
81406 | F8 (coagulation factor VIII) | F8, dup_del | $1227.78 | SE | |
81406 | GAA (glucosidase, alpha; acid) | GAA, fgs | No Data | SE | |
81406 | GALT (galactose-1-phosphate uridylyltransferase) | GALT, fgs | $88.26 | SE | |
81406 | GCDH (glutaryl-CoA dehydrogenase) | GCDH, fgs | No Data | SE | |
81406 | GCK (glucokinase [hexokinase 4]) | GCK, fgs | $356.96 | SE | |
81406 | HADHA (hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein) alpha subunit) | HADHA,fgs | No Data | SE | |
81406 | HEXA (hexosaminidase A, alpha polypeptide) | HEXA, fgs | No Data | SE | |
81406 | HNF4A (hepatocyte nuclear factor 4, alpha) | HNF4A, fgs | $75.88 | SE | |
81406 | IVD (isovaleryl-CoA dehydrogenase) | IVD, fgs | $533.13 | SE | |
81406 | JAG1 (jagged 1) | Jag1, dup_del | No Data | SE | |
81406 | LDB3 (LIM domain binding 3) | LDB3, fgs | No Data | SE | |
81406 | LMNA (lamin A/C) | LMNA, fgs | No Data | SE | |
81406 | MAP2K1 (mitogen-activated protein kinase 1) | MAP2K1, fgs | No Data | SE | |
81406 | MAP2K2 (mitogen-activated protein kinase 2) | MAP2K2, fgs | No Data | SE | |
81406 | MCCC2 (methylcrotonoyl-CoA carboxylase 2 [beta]) | MCCC2, fgs | No Data | SE | |
81406 | MUTYH (mutY homolog (E. coli)) | MUTYH, fgs | $548.35 | SE | |
81406 | NF2 (neurofibromin 2 (merlin)) | NF2, fgs | No Data | SE | |
81406 | NOTCH3 (notch 3) | NOTCH3, tsa | $367.46 | SE | |
81406 | NSD1 (nuclear receptor binding SET domain protein 1) | NSD1, fgs | $945.81 | SE | |
81406 | OPA1 (optic atrophy 1) (e.g., optic atrophy), | OPA1, dup_del | No Data | SE | |
81406 | PAH (phenylalanine hydroxylase) | PAH, fgs | No Data | SE | |
81406 | PALB2 (partner and localizer of BRCA2) | PALB2, fgs | $645.64 | SE | |
81406 | PAX2 (paired box 2) | PAX2, fgs | No Data | SE | |
81406 | PC (pyruvate carboxylase | PC, fgs | $252.68 | SE | |
81406 | PCCB (propionyl CoA carboxylase, beta polypeptide | PCCB, fgs | No Data | SE | |
81406 | PDHA1 (pyruvate dehydrogenase (lipoamide) alpha1) | PDHA1, fgs | No Data | SE | |
81406 | PDHX (pyruvate dehydrogenase complex, component) | PDHX, fgs | $402.56 | SE | |
81406 | POLG (polymerase (DNA directed), gamma) | POLG, fgs | No Data | SE | |
81406 | POMGNT1 (protein O-linked mannose beta1, 2-N acetylglucosaminyltransferase) | POMGNT1, fgs | No Data | SE | |
81406 | POMT1 (protein-O-mannosyltransferase 1) | POMT1, fgs | No Data | SE | |
81406 | POMT2 (protein-O-mannosyltransferase 2) | POMT2, fgs | No Data | SE | |
81406 | PRKAG2 (protein kinase, AMP-activated, gamma 2 non-catalytic subunit) | PRKAG2, fgs | No Data | SE | |
81406 | PSEN2 (presenilin 2[Alzheimer's disease 4]) | PSEN2, fgs | No Data | SE | |
81406 | PTPN11 (protein tyrosine phosphatase, non-receptor type 11) | PTPN11, fgs | No Data | SE | |
81406 | PYGM (phosphorylase, glycogen, muscle) | PYGM, fgs | $664.21 | SE | |
81406 | RYR1 (ryanodine receptor 1, skeletal) | RYR1, tsa | No Data | SE | |
81406 | RAF1 (v-raf-1 murine leukemia viral oncogene homolog 1) | RAF1, fgs | No Data | SE | |
81406 | RET (ret-proto-oncogene) | RET, fgs | $168.83 | Y | |
81406 | SLC26A4 (solute carrier family 26, member 4) | SLC26A4, fgs | No Data | SE | |
81406 | SLC9A6 (solute carrier family 9 (sodium/hydrogen exchanger) member 6) | SLC9A6, fgs | $687.44 | SE | |
81406 | SOS1 (son of sevenless homolog 1) | SOS1, fgs | $990.66 | SE | |
81406 | TAZ (tafazzin) | TAZ, fgs | No Data | SE | |
81406 | TNNT2 (troponin T, type 2[cardiac]) | TNNT2, fgs | No Data | SE | |
81406 | TSC1 (tuberous sclerosis 1) | TSC1, fgs | No Data | SE | |
81406 | TSC2 (tuberous sclerosis 2) | TSC2, dup_del | No Data | SE | |
81406 | UBE3A (ubiquitin protein ligase) | UBE3A, fgs | $794.78 | SE | |
81406 | VWF (von Willebrand factor) | VWF, etsa | No Data | SE | |
81407 | Mopath procedure level 8 | ||||
81407 | ABCC8 (ATP-binding cassette, sub-family C [CFTR/MRP], member 8) | ABCC8, fgs | No Data | SE | |
81407 | CHD7 (chromodomain helicase DNA binding protein 7) | CHD7, fgs | No Data | SE | |
81407 | F8 (coagulation factor VIII) | F8, fgs | $1649.42 | SE | |
81407 | JAG1 (jagged 1) | JAG1, fgs | No Data | SE | |
81407 | MYBPC3 (myosin binding protein C, cardiac) | MYBPC3, fgs | No Data | SE | |
81407 | MYH6 (myosin, heavy chain 6, cardiac muscle, alpha) | MYH6, fgs | No Data | SE | |
81407 | MYH7 (myosin, heavy chain 7, cardiac muscle, beta) | MYH7, fgs | No Data | SE | |
81407 | MYO7A (myosin VIIA) | MYO7A, fgs | No Data | SE | |
81407 | NOTCH1 (notch 1) | NOTCH1, fgs | No Data | SE | |
81407 | OPA1 (optic atrophy) | OPA1, fgs | No Data | SE | |
81407 | PCDH15 (protocadherin-related 15) | PCDH15, fgs | No Data | SE | |
81407 | SCN1A (sodium channel, voltage-gated, type 1, alpha subunit) | SCN1A, fgs | No Data | SE | |
81407 | SCN5A (sodium channel, voltage-gated, type V, alpha subunit) | SCN5A, fgs | No Data | SE | |
81407 | TSC2 (tuberous sclerosis 2) | TSC2, fgs | No Data | SE | |
81407 | USH1C (Usher syndrome 1C [autosomal recessive, severe]) | USH1C, fgs | No Data | SE | |
81408 | Mopath procedure level 9 | ||||
81408 | ATM (ataxia telangiectasia mutated) | ATM, fgs | No Data | SE | |
81408 | CDH23 (cadherin-related 23) | CDH23, fgs | No Data | SE | |
81408 | COL1A1 (collagen, type I, alpha 1) | COL1A1, fgs | No Data | SE | |
81408 | COL1A2 (collagen, type I, alpha 2) | COL1A2, fgs | No Data | SE | |
81408 | DYSF (dysferlin, limb girdle muscular dystrophy 2B [autosomal recessive]) | DYSF, fgs | No Data | SE | |
81408 | FBN1 (fibrillin 1 | FBN1, fgs | No Data | SE | |
81408 | NF1 (neurofibromin 1) | NF1, fgs | No Data | SE | |
81408 | RYR1 (ryanodine receptor 1, skeletal) | RYR1, fgs | No Data | SE | |
81408 | USH2A (Usher syndrome 2A [autosomal recessive, mild]) | USH2A, fgs | No Data | SE | |
81408 | VWF (von Willebrand factor) (e.g., von Willebrand disease types 1 and 3), | VWF, fgs | No Data | SE |
Descriptor column abbreviation key
Abbreviation Key | lower case claim text |
---|---|
Amplified | amp |
Additional | add |
Breakpoints | bp |
Common | c |
common duplications_deletions | cdup_del |
common variants | cv |
common breakpoints | cbp |
Deletion | del |
direct probe | dp |
Duplication | dup |
duplication_deletion | dup_del |
Each | ea |
extended targeted sequence analysis | etsa |
full gene sequence | fgs |
gene rearrangement | gr |
high resolution | hr |
insertion/deletion variant | idv |
inversion analysis | ia |
known familial variants | kfv |
low resolution | lr |
major breakpoint | majbp |
major breakpoint region | mbpr |
methylation analysis | ma |
Microsatellite instability | MSI |
minor breakpoint | minbp |
minor cluster region | mcr |
Number | nmbr |
Qualitative | qual |
Quantitative | quan |
short tandem repeat | str |
single breakpoint | sbp |
somatic mutation | sm |
tandem repeat variant | trv |
targeted gene analysis | tga |
targeted sequence analysis | tsa |
translocation analysis | ta |
Variant | var |